Matthew Liddelow

Matthew Liddelow has over 12 years of experience in the commercialisation of biotechnology, medical devices and pharmaceuticals. Mr Liddelow has been involved in a number of startup companies including device company Medevco, which was acquired by Allied Healthcare Group (now Admedus). While employed by multi-national pharmaceutical company AstraZeneca, Mr Liddelow gained first-hand experience in the development, marketing and product launch of cardio vascular and respiratory related medications. In 2014, Mr Liddelow founded Enhanced Biomedical (deregistered in 2016), a medical device distribution business of which he was managing director.
Bio last updated 04 Aug 2018

Access to our data for Matthew Liddelow is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Matthew Liddelow is linked to 1 organisation which is included in 1 list - Public Companies - Industrial.

To see the data you will need to .

Total Shareholder Return as at 31/10/18

1 year TSR5 year TSR
thNeuroScientific Biopharmaceuticals0%0%
744 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar


Chief Executive, Managing Director
Year started and most recent title

BNiQ Disclaimer